CRMD — CorMedix Cashflow Statement
0.000.00%
Last trade - 00:00
- $215.53m
- $139.50m
- 17
- 17
- 66
- 25
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -16.4 | -22 | -28.2 | -29.7 | -46.3 |
Depreciation | |||||
Non-Cash Items | 3.24 | 2.56 | 5.16 | 4.19 | 5.63 |
Other Non-Cash Items | |||||
Changes in Working Capital | -1.93 | -2.63 | 1.84 | 1.07 | 2.23 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -15.1 | -22 | -21.2 | -24.4 | -38.4 |
Capital Expenditures | -0.037 | -0.113 | -1.43 | -0.219 | -0.327 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -12 | 7.54 | -7.71 | -3.49 | -16.7 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -12 | 7.43 | -9.13 | -3.71 | -17.1 |
Financing Cash Flow Items | -0.227 | 0 | — | — | -0.198 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 25.8 | 40.1 | 41.8 | 17.9 | 55.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.27 | 25.6 | 11.5 | -10.2 | 0.448 |